Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Air Polishing for Pain and Compliance in Supportive Periodontal Therapy

20. September 2026 aktualisiert von: Octavi Camps-Font

Efficacy of Air Polishing on Pain Perception and Compliance With Supportive Periodontal Therapy: A Randomized Clinical Trial

Supportive periodontal therapy (SPT) is essential for maintaining periodontal stability and preventing disease recurrence in patients who have been successfully treated for periodontitis. However, long-term effectiveness depends on regular attendance at maintenance visits, and negative experiences associated with periodontal instrumentation, such as pain or discomfort, may affect patient acceptance and adherence to the maintenance program.

The aim of this randomized clinical trial is to evaluate whether supportive periodontal therapy performed using an air-polishing device with low-abrasive trehalose powder reduces patient-perceived pain and improves the clinical experience compared with conventional biofilm removal using ultrasonic instrumentation. The study will also assess whether the use of air polishing is associated with better adherence to the periodontal maintenance program while maintaining comparable periodontal clinical outcomes.

Forty periodontally stabilized adult patients enrolled in the supportive periodontal therapy program of the Master's Degree in Periodontology and Peri-implantology at the University of Barcelona will be randomly allocated in a 1:1 ratio to one of two parallel treatment groups. The control group will receive conventional supportive periodontal therapy using ultrasonic instrumentation, while the experimental group will receive supportive periodontal therapy using an air-polishing device with low-abrasive trehalose powder. Participants will be followed for 24 months.

The primary outcome will be patient-perceived pain associated with supportive periodontal therapy, assessed using a visual analogue scale (VAS). Secondary outcomes will include treatment duration, adherence to scheduled maintenance visits, patient experience and acceptance of treatment, and periodontal clinical parameters. Periodontal status will be monitored throughout follow-up by assessing probing pocket depth, clinical attachment level, bleeding on probing, and plaque index.

This study aims to determine whether air polishing with trehalose powder can provide a more comfortable and patient-centered approach to supportive periodontal therapy without compromising periodontal clinical outcomes, and whether an improved treatment experience may contribute to better long-term adherence to periodontal maintenance.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Detaillierte Beschreibung

Periodontitis is a chronic inflammatory disease that requires long-term supportive periodontal therapy (SPT) after completion of active periodontal treatment in order to maintain periodontal stability and reduce the risk of disease recurrence. The effectiveness of SPT is strongly influenced by long-term patient adherence. Therefore, improving patient comfort and treatment experience during maintenance visits may contribute to better adherence to periodontal maintenance programs.

Conventional SPT commonly involves mechanical removal of supra- and subgingival biofilm and deposits using ultrasonic instrumentation. Air-polishing devices using low-abrasive powders have been proposed as an alternative approach for biofilm removal during periodontal maintenance. Previous studies suggest that air polishing may provide effective biofilm removal while reducing patient discomfort and treatment time. However, evidence regarding the use of newer-generation air-polishing systems with trehalose-based powder during SPT remains limited. This study will therefore evaluate both patient-reported outcomes and periodontal clinical outcomes associated with this approach.

This study is designed as a randomized, superiority, parallel-group clinical trial with a 24-month follow-up period. A total of 40 periodontally stabilized adult patients enrolled in the SPT program of the Master's Degree in Periodontology and Peri-implantology at the University of Barcelona will be included. Participants who meet the eligibility criteria and provide written informed consent will be randomly allocated in a 1:1 ratio to either the experimental group or the control group, with an expected sample of 20 participants per group.

Participants allocated to the control group will receive conventional biofilm removal using ultrasonic instrumentation during supportive periodontal therapy. Participants allocated to the experimental group will receive supportive periodontal therapy using an air-polishing device with low-abrasive trehalose powder. The purpose of this comparison is to determine whether the air-polishing approach reduces patient-perceived pain and improves the overall treatment experience and adherence to the maintenance program compared with conventional ultrasonic instrumentation, while maintaining comparable periodontal clinical outcomes.

Participants will be prospectively evaluated at baseline and during follow-up visits over a period of 24 months. Maintenance visits will be performed every 6 months. At each maintenance visit, a complete periodontal examination will be performed. Periodontal clinical parameters will include probing pocket depth, clinical attachment level, bleeding on probing, and plaque index.

The primary outcome of the study will be patient-perceived pain associated with supportive periodontal therapy. Immediately after treatment, perceived pain will be assessed using a visual analogue scale (VAS). Secondary outcomes will include patient experience, adherence to the periodontal maintenance program, treatment duration, and periodontal clinical outcomes. Adherence will be evaluated according to attendance at scheduled maintenance visits throughout the follow-up period.

Data will be prospectively collected using a specific electronic data collection form, including demographic and clinical variables as well as patient-experience questionnaires. Investigators responsible for clinical examinations will undergo calibration before participant recruitment.

Statistical analyses will be conducted according to the intention-to-treat principle, with patient-perceived pain considered the primary outcome variable. The study is designed to determine whether the use of air polishing with trehalose powder provides a superior patient experience, particularly in terms of perceived pain, compared with conventional ultrasonic instrumentation, while also assessing whether both approaches provide comparable periodontal clinical outcomes over time.

The study will be conducted at the University of Barcelona Dental Hospital (Hospital Odontològic Universitat de Barcelona), in the clinical facilities of the Master's Degree in Periodontology and Peri-implantology. Recruitment, diagnosis, and treatment of participants will be performed by residents of the Master's program under the supervision of the study investigators.

By simultaneously evaluating patient-reported outcomes, adherence, treatment efficiency, and periodontal clinical parameters, this study seeks to determine whether air polishing with trehalose powder may represent a more comfortable and patient-centered approach to supportive periodontal therapy without compromising periodontal stability. If improved comfort is associated with better adherence to scheduled maintenance visits, this approach could contribute to optimizing long-term periodontal maintenance protocols.

Studientyp

Interventionell

Einschreibung (Geschätzt)

40

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

  • Name: Octavi Camps Font, DDS, MSc, PhD
  • Telefonnummer: +34 665980569
  • E-Mail: ocamps@ub.edu

Studienorte

    • Barcelona
      • L'Hospitalet de Llobregat, Barcelona, Spanien, 08907
        • Hospital Odontològic Universitat de Barcelona
        • Kontakt:
          • Octavi Camps Font, DDS, MSc, PhD
          • Telefonnummer: +34 665980569
          • E-Mail: ocamps@ub.edu
        • Kontakt:
        • Unterermittler:
          • Enrique Manuel Roldán Carrera, DDS, MSc
        • Unterermittler:
          • Albert González Barnadas, DDS, MSc, PhD
        • Unterermittler:
          • Jaume Miranda Rius, DDS, MSc, PhD

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Men or women aged 18 years or older who voluntarily agree to sign the informed consent form before any study-related procedure is performed.
  • ASA physical status I or II.
  • Initial diagnosis of Stage I-III periodontitis according to the 2017 World Workshop, periodontally treated and stabilized, and enrolled in a supportive periodontal therapy (SPT) program.
  • Non-smokers or light smokers (<10 cigarettes/day).
  • Commitment to attend all follow-up visits over the 24-month study period.

Exclusion Criteria:

  • Patients requiring local anesthesia or anxiolytic premedication to undergo supportive periodontal therapy (SPT).
  • Patients with pacemakers, implantable cardioverter-defibrillators, or neurostimulators.
  • Pregnant women.
  • Patients with infectious respiratory diseases.
  • Patients with systemic diseases or neurological disorders that may alter pain perception.
  • Patients receiving medications that may influence pain perception (e.g., opioids or gabapentin).

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Trehalose Air-Polishing Group

Participants allocated to this group will receive supportive periodontal therapy (SPT) using an air-polishing device with low-abrasive trehalose powder for subgingival biofilm removal.

Subgingival biofilm removal during supportive periodontal therapy using an air-polishing device with low-abrasive trehalose powder.

Aktiver Komparator: Ultrasonic Instrumentation Group

Participants allocated to this group will receive supportive periodontal therapy (SPT) using conventional ultrasonic instrumentation for subgingival biofilm and calculus removal.

Conventional subgingival debridement during supportive periodontal therapy using ultrasonic instrumentation.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Pain perceived during supportive periodontal therapy
Zeitfenster: Immediately after the supportive periodontal therapy session

Pain perceived by the participant during the supportive periodontal therapy session will be assessed using a Visual Analogue Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). The outcome will be compared between participants treated with trehalose air-polishing and those treated with ultrasonic instrumentation.

Immediately after the supportive periodontal therapy session

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Patient-reported treatment experience
Zeitfenster: Immediately after each supportive periodontal therapy session

Patient-reported experience with supportive periodontal therapy will be assessed using a structured questionnaire after treatment. The questionnaire will evaluate aspects related to comfort, treatment perception, satisfaction, and preference, allowing comparison between trehalose air-polishing and ultrasonic instrumentation.

Immediately after each supportive periodontal therapy session
Duration of supportive periodontal therapy session
Zeitfenster: At each supportive periodontal therapy visit throughout the 24-month follow-up

Duration of the supportive periodontal therapy session, measured in minutes from the effective start of the clinical procedure until completion of the periodontal treatment scheduled for that visit.

At each supportive periodontal therapy visit throughout the 24-month follow-up
Adherence to supportive periodontal therapy
Zeitfenster: Throughout the 24-month follow-up

Adherence to the supportive periodontal therapy program will be assessed based on attendance at scheduled maintenance visits. Adherence will be determined from the proportion of scheduled visits attended by each participant during the follow-up period.

Throughout the 24-month follow-up
Probing pocket depth (PPD)
Zeitfenster: Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up

Probing pocket depth will be measured at six sites per tooth using a UNC-15 periodontal probe and expressed in millimeters.

Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up
Clinical attachment level (CAL)
Zeitfenster: Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.

Clinical attachment level will be measured at six sites per tooth using a UNC-15 periodontal probe and expressed in millimeters.

Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.
Gingival margin position (MG)
Zeitfenster: Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.

Gingival margin position will be measured at six sites per tooth using a UNC-15 periodontal probe and expressed in millimeters.

Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.
Bleeding on probin (BoP)
Zeitfenster: Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.

Bleeding on probing will be recorded at six sites per tooth and expressed as the percentage of sites presenting bleeding after periodontal probing.

Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.
Plaque index (PI)
Zeitfenster: Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.

Plaque will be recorded at six sites per tooth and expressed as the percentage of sites presenting plaque.

Baseline and at each supportive periodontal therapy visit throughout the 24-month follow-up.
Patient knowledge and awareness of supportive periodontal therapy
Zeitfenster: Throughout the 24-month follow-up

Patient knowledge and awareness regarding periodontitis and the importance of supportive periodontal therapy will be assessed using an 8-item questionnaire. Each correct response will receive 1 point and each incorrect response 0 points, resulting in a total score ranging from 0 to 8. Higher scores indicate greater knowledge and awareness of periodontitis and supportive periodontal therapy.

Throughout the 24-month follow-up
Patient-reported perceived knowledge of periodontal disease and supportive periodontal therapy
Zeitfenster: Throughout the 24-month follow-up.

Participants will rate their perceived level of knowledge regarding their periodontal disease and supportive periodontal therapy on a numerical rating scale ranging from 1 to 10, with higher scores indicating a greater self-perceived level of knowledge.

Throughout the 24-month follow-up.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Edgar Martínez García, DDS, University of Barcelona

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. Oktober 2026

Primärer Abschluss (Geschätzt)

1. Oktober 2026

Studienabschluss (Geschätzt)

1. Mai 2027

Studienanmeldedaten

Zuerst eingereicht

12. September 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

20. September 2026

Zuerst gepostet (Tatsächlich)

24. September 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

24. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

20. September 2026

Zuletzt verifiziert

1. September 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Individual participant data (IPD) will not be shared with external researchers, in accordance with the study protocol and applicable data protection regulations.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren